Business Insider India
Bharat Biotech’s coronavirus vaccine Covaxin is the first COVID-19 vaccine to get DGCI’s (Drug Controller General of India) nod.
The drug regulatory body allowed the pharma company to conduct phase I and phase-II clinical trials.
The vaccine was developed in collaboration with the National Institute of Virology, IndianCouncil of Medical Research (ICMR).
The human trials of Covaxin…